Benítez-Fernández, R.; Gil, C.; Guaza, C.; Mestre, L.; Martínez, A.
The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis. Int. J. Mol. Sci. 2022, 23, 14378.
https://doi.org/10.3390/ijms232214378
AMA Style
Benítez-Fernández R, Gil C, Guaza C, Mestre L, Martínez A.
The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis. International Journal of Molecular Sciences. 2022; 23(22):14378.
https://doi.org/10.3390/ijms232214378
Chicago/Turabian Style
Benítez-Fernández, Rocio, Carmen Gil, Carmen Guaza, Leyre Mestre, and Ana Martínez.
2022. "The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis" International Journal of Molecular Sciences 23, no. 22: 14378.
https://doi.org/10.3390/ijms232214378
APA Style
Benítez-Fernández, R., Gil, C., Guaza, C., Mestre, L., & Martínez, A.
(2022). The Dual PDE7-GSK3β Inhibitor, VP3.15, as Neuroprotective Disease-Modifying Treatment in a Model of Primary Progressive Multiple Sclerosis. International Journal of Molecular Sciences, 23(22), 14378.
https://doi.org/10.3390/ijms232214378